Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systems Biology of Zoster Vaccine Recombinant, Adjuvanted (SHINGRIX)

NCT04047979 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT04047979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04047979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systems Biology of Zoster Vaccine Recombinant, Adjuvanted (SHINGRIX)
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Completed
Start date
November 14, 2019
Completion date
October 30, 2023
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chicken pox, shingles, zoster, zoster varicella